This painting received an Rx Club Award of Excellence. It depicts the mode of action of the drug Lucentis used in the treatment of wet age-related macular degeneration (wet AMD). The scene shows the stylized drug molecules binding and inactivating VEGF molecules (involved in the pathogenesis of the disease) within the choroid layer of the eye.
Keywords: 3D, Models, Advertising / Marketing, Editorial, Web, Allergy / Immunology, Biotechnology, Cell biology / Histology, Disease Management, Ophthalmology
© Audra Geras